Cyclooxygenase-2 Inhibitors in Postoperative Pain Management: Current Evidence and Future Directions

Anesthesiology

Volumn 99, Issue 5, 2003, Pages 1198-1208

  Gilron, Ian ^a   Milne, Brian ^b   Hong, Murray ^b  

^a QUEEN S UNIVERSITY   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CELECOXIB; CODEINE; CYCLOOXYGENASE 2 INHIBITOR; DICLOFENAC; IBUPROFEN; INDOMETACIN; KETOROLAC; MELOXICAM; NIMESULIDE; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; PARECOXIB; PIROXICAM; ROFECOXIB; VALDECOXIB;

ANAPHYLAXIS; ANGINA PECTORIS; ASEPTIC MENINGITIS; BLEEDING TENDENCY; CARDIOTOXICITY; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CONVALESCENCE; COST EFFECTIVENESS ANALYSIS; DIGESTIVE SYSTEM PERFORATION; DRUG EFFICACY; DRUG SAFETY; DRUG SELECTIVITY; FRACTURE HEALING; GASTRITIS; GASTROINTESTINAL HEMORRHAGE; GLOMERULUS FILTRATION RATE; HEART INFARCTION; HIGH RISK PATIENT; HUMAN; KIDNEY DYSFUNCTION; KIDNEY FAILURE; KIDNEY INJURY; LIVER CELL DAMAGE; OLIGURIA; POSTOPERATIVE ANALGESIA; POSTOPERATIVE PAIN; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SIDE EFFECT; SODIUM RETENTION; STOMACH ULCER; THROMBOSIS; TINNITUS; URTICARIA;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ARTHRITIS; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; CYCLOOXYGENASE INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; ISOENZYMES; MEMBRANE PROTEINS; PAIN, POSTOPERATIVE; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES;

EID: 0242302548     PISSN: 00033022     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000542-200311000-00029     Document Type: Review

References (125)

1. White PF: The role of non-opioid analgesic techniques in the management of pain after ambulatory surgery. Anesth Analg 2002; 94:577-85
2. Bloomfield SS, Gaffney TE, Howett M: Comparative analgesic efficacy of chlorphenesin carbamate and acetylsalicylic acid after episiotomy. Anesth Analg 1967; 46:515-20
3. Hackl J: Treatment of postoperative pain with mefenamic acid. Med Welt 1967; 46:2796-9
4. Smith LA, Carroll D, Edwards JE, Moore RA, McQuay HJ: Single-dose ketorolac and pethidine in acute postoperative pain: Systematic review with meta-analysis. Br J Anaesth 2000; 84:48-58
5. Edwards JE, Oldman AD, Smith LA, Carroll D, Wiffen PJ, McQuay HJ, Moore RA: Oral aspirin in postoperative pain: A quantitative systematic review. Pain 1999; 81:289-97
6. Po Al, Zhang WY: Analgesic efficacy of ibuprofen alone and in combination with codeine or caffeine in post-surgical pain: A meta-analysis. Eur J Clin Pharmacol 1998; 53:303-11
7. Tverskoy M, Oren M, Dashkovsky I, Kissin I: Alfentanil dose-response relationships for relief of postoperative pain. Anesth Analg 1996; 83:387-93
8. Wilder-Smith CH, Hill L, Wilkins J, Denny L Effects of morphine and tramadol on somatic and visceral sensory function and gastrointestinal motility after abdominal surgery. ANESTHESIOLOGY 1999; 91:639-47
9. Keenan DJ, Cave K, Langdon L, Lea RE: Comparative trial of rectal indomethacin and cryoanalgesia for control of early postthoracotomy pain. BMJ 1983; 287:1335-7
10. Pavy TJ, Gambling DR, Merrick PM, Douglas MJ: Rectal indomethacin potentiates spinal morphine analgesia after caesarean delivery. Anaesth Intensive Care 1995; 23:555-9
11. Gilron I, Max MB, Lee G, Booher SL, Sang CN, Chappell AS, Dionne RA: Effects of the 2-amino-3-hydroxy-5-methyl-4-isoxazole-proprionic acid/kainate antagonist LY293558 on spontaneous and evoked postoperative pain. Clin Pharmacol Ther 2000; 68:320-7
12. Richardson J, Sabanathan S, Shah R: Post-thoracotomy spirometric lung function: The effect of analgesia: A review. J Cardiovasc Surg 1999; 40:445-56
13. Gilron I, Tod D, Goldstein DH, Parlow JL, Orr E: The relationship between movement-evoked versus spontaneous pain and peak expiratory flow after abdominal hysterectomy. Anesth Analg 2002; 95:1702-7
14. Parker RK, Holtmann B, Smith I, White PF: Use of ketorolac after lower abdominal surgery: Effect on analgesic requirement and surgical outcome ANESTHESIOLOGY 1994; 80:6-12
15. Reuben SS, Connelly NR, Lurie S, Klatt M, Gibson CS: Dose-response of ketorolac as an adjunct to patient-controlled analgesia morphine in patients after spinal fusion surgery. Anesth Analg 1998; 87:98-102
16. Ogilvie-Harris DJ, Bauer M, Corey P: Prostaglandin inhibition and the rate of recovery after arthroscopic meniscectomy: A randomised double-blind prospective study. J Bone Joint Surg Br 1985; 67:567-71
17. Place RJ, Coloma M, White PF, Huber PJ, Van Vlymen J, Simmang CL: Ketorolac improves recovery after outpatient anorectal surgery. Dis Colon Rectum 2000; 43:804-8
18. Kehlet H, Werner M, Perkins F: Balanced analgesia: What is it and what are its advantages in postoperative pain? Drugs 1999; 58:793-7
19. Cuthbert MF: Adverse reactions to non-steroidal antirheumatic drugs. Curr Med Res Opin 1974; 2:600-10
20. O'Brien WM, Bagby GF: Rare adverse reactions to nonsteroidal antiinflammatory drugs. J Rheumatol 1985; 12:785-90
21. Souter AJ, Fredman B, White PF: Controversies in the perioperative use of nonsteroidal antiinflammatory drugs. Anesth Analg 1994; 79:1178-90
22. Lee A, Cooper MG, Craig JC, Knight JF, Keneally JP: The effects of nonsteroidal anti-inflammatory drugs (NSAIDs) on postoperative renal function: A meta-analysis. Anaesth Intensive Care 1999; 27:574-80
23. Miller FC, Schorr WJ, Lacher JW: Zomepirac-induced renal failure. Arch Intern Med 1983; 143:1171-3
24. Perazella MA, Buller GK: NSAID nephrotoxicity revisited: Acute renal failure due to parenteral ketorolac. South Med J 1993; 86:1421-4
25. Quan DJ, Kayser SR: Ketorolac induced acute renal failure following a single dose. J Toxicol Clin Toxicol 1994; 32:305-9
26. Haragsim L, Dalal R, Bagga H, Bastani B: Ketorolac-induced acute renal failure and hyperkalemia: Report of three cases. Am J Kidney Dis 1994; 24: 578-80
27. Patel NY, Landercasper J: Ketorolac-induced postoperative acute renal failure: A case report. Wis Med J 1995; 94:445-7
28. Sivarajan M, Wasse L: Perioperative acute renal failure associated with preoperative intake of ibuprofen. ANESTHESIOLOGY 1997; 86:1390-2
29. McCann KJ, Irish J: Postoperative gastrointestinal bleeding: A case report involving a non-steroidal anti-inflammatory drug. J Can Dent Assoc 1994; 60: 124-8
30. Wolfe PA, Polhamus CD, Kubik C, Robinson AB, Clement DJ: Giant duodenal ulcers associated with the postoperative use of ketorolac: Report of three cases. Am J Gastroenterol 1994; 89:1110-1
31. Yarboro TL Sr: Intramuscular Toradol, gastrointestinal bleeding, and peptic ulcer perforation: A case report. J Natl Med Assoc 1995; 87:225-7
32. Buchman AL, Schwartz MR: Colonic ulceration associated with the systemic use of nonsteroidal antiinflammatory medication. J Clin Gastroenterol 1996; 22:224-6
33. Alcaraz A, Lopez-Herce J, Serina C, Bueso-Inchausti A, Saez MJ, Sancho L: Gastrointestinal bleeding following ketorolac administration in a pediatric patient. J Pediatr Gastroenterol Nutr 1996; 23:479-81
34. Fauno P, Petersen KD, Husted SE: Increased blood loss after preoperative NSAID: Retrospective study of 186 hip arthroplasties. Acta Orthop Scand 1993; 64:522-4
35. Robinson CM, Christie J, Malcolm-Smith N: Nonsteroidal antiinflammatory drugs, perioperative blood loss, and transfusion requirements in elective hip arthroplasty. J Arthroplasty 1993; 8:607-10
36. Splinter WM, Rhine EJ, Roberts DW, Reid CW, MacNeill HB: Preoperative ketorolac increases bleeding after tonsillectomy in children. Can J Anaesth 1996; 43:560-3
37. Wierod FS, Frandsen NJ, Jacobsen JD, Hartvigsen A, Olsen PR: Risk of haemorrhage from transurethral prostatectomy in acetylsalicylic acid and NSAID-treated patients. Scand J Urol Nephrol 1998; 32:120-2
38. Schmidt A, Bjorkman S, Akeson J: Preoperative rectal diclofenac versus paracetamol for tonsillectomy: Effects on pain and blood loss. Acta Anaesthesiol Scand 2001; 45:48-52
39. Lewis JH: Hepatic toxicity of nonsteroidal anti-inflammatory drugs. Clin Pharm 1984; 3:128-38
40. Stevenson DD: Diagnosis, prevention, and treatment of adverse reactions to aspirin and nonsteroidal anti-inflammatory drugs. J Allergy Clin Immunol 1984; 74:617-22
41. Myoshi HR: Systemic nonopioid analgesics, Bonica's Management of Pain, 3rd edition. Edited by Loeser JD, Turk D, Chapman CR, Butler S. Philadelphia, Williams & Wilkins, 2001, pp 1667-81
42. Vane JR: Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nat New Biol 1971; 231:232-5
43. Smith WL, DeWitt DL, Garavito RM: Cyclooxygenases: Structural, cellular, and molecular biology. Annu Rev Biochem 2000; 69:145-82
44. Dahl JB, Kehlet H: Non-steroidal anti-inflammatory drugs: Rationale for use in severe postoperative pain. Br J Anaesth 1991; 66:703-12
45. Goetz EJ, An S, Smith WL: Specificity of expression and effects of eicosanoid mediators in normal physiology and human diseases. FASEB J 1995; 9:1051-8
46. Taiwo YO, Levine JD: Indomethacin blocks central nociceptive effects of PGF2 alpha. Brain Res 1986; 373:81-4
47. Malmberg AB, Yaksh TL: Hyperalgesia mediated by spinal glutamate or substance P receptor blocked by spinal cyclooxygenase inhibition. Science 1992; 257:1276-9
48. Milne B, Hall SR, Sullivan ME, Loomis C: The release of spinal prostaglandin E2 and the effect of nitric oxide synthetase inhibition during strychnine-induced allodynia. Anesth Analg 2001; 93:728-33
49. Svensson CI, Yaksh TL: The spinal phospholipase-cyclooxygenase-prostanoid cascade in nociceptive processing. Annu Rev Pharmacol Toxicol 2002; 42:553-83
50. Mahmud T, Scott DL, Bjarnason I: A unifying hypothesis for the mechanism of action of NSAID related gastrointestinal toxicity. Ann Rheum Dis 1996; 55:211-3
51. Ruilope LM, Garcia Robles R, Paya C, Alcazar JM, Miravalles E, Sancho-Rof J, Rodicio J, Knox FG, Romero JC: Effects of long-term treatment with indomethacin on renal function. Hypertension 1986; 8:677-84
52. Schafer AI: Effects of nonsteroidal antiinflammatory drugs on platelet function and systemic hemostasis. J Clin Pharmacol 1995; 35:209-19
53. Szczeklik A: The cyclooxygenase theory of aspirin-induced asthma. Eur Respir J 1990; 3:588-93
54. Tornkist H, Nilsson OS, Bauer FC, Lindholm TS: Experimentally induced heterotopic ossification in rats influenced by anti-inflammatory drugs. Scand J Rheumatol 1983; 12:177-80
55. Merlie JP, Fagan D, Mudd J, Needleman P: Isolation and characterization of the complementary DNA for sheep seminal vesicle prostaglandin endoperoxide synthase (cyclooxylgenase). J Biol Chem 1988; 263:3550-3
56. Hla T. Neilson K: Human cyclooxygenase-2 cDNA. Proc Natl Acad Sci USA 1992; 89:7384-8
57. O'Banion MK, Winn VD, Young DA: cDNA cloning and functional activity of a glucocorticoid-regulated inflammatory cyclooxygenase. Proc Natl Acad Sci USA 1992; 89:4888-92
58. Pairet M, van Ryn J: Experimental models used to investigate the differential inhibition of cyclooxygenase-1 and cyclooxygenase-2 by non-steroidal antiinflammatory drugs. Inflamm Res 1998; 47:93-101
59. Mitchell JA, Akarasereenont P, Thiemermann C, Flower RJ, Vane JR: Selectivity of nonsteroidal antiinflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase. Proc Natl Acad Sci USA 1993; 90:11693-7
60. Patrignani P, Panara MR, Sciulli MG, Santini G, Renda G, Patrono C: Differential inhibition of human prostaglandin endoperoxide synthase-1 and -2 by nonsteroidal anti-inflammatory drugs. J Physiol Pharmacol 1997; 48:623-31
61. Chan CC, Boyce S, Brideau C, Charleson S, Cromlish W, Ethier D, Evans J, Ford-Hutchinson AW, Forrest MJ, Gauthier JY, Gordon R, Gresser M, Guay J, Kargman S. Kennedy B, Leblanc Y, Leger S, Mancini J, O'Neill GP, Ouellet M, Patrick D, Percival MD, Perrier H, Prasit P, Rodger I, Tagari P, Therien M, Vickers P, Visco D, Wang Z, Webb J, Wong E, Xu LJ, Young RN, Zamboni R, Riendeau D: Rofecoxib [Vioxx, MK-0966; 4-(4′ -methylsulfonylphenyl)-3-phenyl-2(5H)-furanone]: A potent and orally active cyclooxygenase-2 inhibitor. Pharmacological and biochemical profiles. J Pharmacol Exp Ther 1999; 290:551-60
62. Vane JR, Bakhle YS, Botting RM: Cyclooxygenases 1 and 2. Annu Rev Pharmacol Toxicol 1998; 38:97-120
63. Funk CD: Prostaglandins and leukotrienes: Advances in eicosanoid biology. Science 2001; 294:1871-5
64. Simon LS, Lanza FL, Lipsky PE, Hubbard RC, Talwalker S, Schwartz BD, Isakson PC, Geis GS: Preliminary study of the safety and efficacy of SC-58635, a novel cyclooxygenase 2 inhibitor: Efficacy and safety in two placebo-controlled trials in osteoarthritis and rheumatoid arthritis, and studies of gastrointestinal and platelet effects. Arthritis Rheum 1998; 41:1591-602
65. Hirata T, Ukawa H, Yamakuni H, Kato S, Takeuchi K: Cyclo-oxygenase isozymes in mucosal ulcergenic and functional responses following barrier disruption in rat stomachs. Br J Pharmacol 1997; 122:447-54
66. Chan CC, Boyce S, Brideau C, Ford-Hutchinson AW, Gordon R, Guay D, Hill RG, Li CS, Mancini J, Penneton M: Pharmacology of a selective cyclooxygenase-2 inhibitor, L-745, 337: A novel nonsteroidal anti-inflammatory agent with an ulcerogenic sparing effect in rat and nonhuman primate stomach. J Pharmacol Exp Ther 1995; 274:1531-7
67. Bombardier C, Laine L, Reicin A, Shapiro D, Burgos-Vargas R, Davis B, Day R, Ferraz MB, Hawkey CJ, Hochberg MC, Kvien TK, Schnitzer TJ: Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR study group. N Engl J Med 2000; 343:1520-8
68. Silverstein FE, Faich G, Goldstein JL, Simon LS, Pincus T, Whelton A, Makuch R, Eisen G, Agrwal NM. Stenson WF, Burr AM, Zhao WW, Kent JD, Letkowith JB, Verhurg KM, Geis GS: Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: The CLASS study. A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study. JAMA 2000; 284:1247-55
69. Brune K: Non-opioid (antipyretic) analgesics, Pain 2002: An Updated Review. Edited by Giamberardino MA. Seattle, IASP Press, 2002, pp 365-79
70. Giovanucci E, Egan KM, Hunter DJ, Stampfer MJ, Colditz GA, Willett WC, Speizer FE: Aspirin and the risk of colorectal cancer in women. N Engl J Med 1995; 333:609-14
71. Stewart WF, Kawas C, Corrada M, Metter EJ: Risk of Alzheimer's disease and duration of NSAID use. Neurology 1997; 48:626-32
72. Brater DC: Renal effects of cyclooxygenase-2-selective inhibitors. J Pain Symptom Manage 2002; 23:S15-20
73. Poldermans D, Boersma E, Bax JJ, Thomson IR, van de Ven LL, Blankensteijn JD, Baars HF, Yo TI, Trocino G, Vigna C, Roelandt JR, van Urk H: The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery. N Engl J Med 1999; 341:1789-94
74. Reitblat T, Zamir D, Estis L, Priluk R, Drogenikov T, Viskoper JR: The different patterns of blood pressure elevation by rofecoxib and nabumetone. J Hum Hypertens 2002; 16:431-4
75. Max MB, Laska EM: Single-dose analgesic comparisons, Advances in Pain Research and Therapy. Vol 18. Edited by Max M, Portenoy R, Laska E. New York, Raven Press, 1991
76. Food and Drug Administration: Guideline for the Clinical Evaluation of Analgesic Drugs. Rockville, U.S. Department of Health and Human Services, 1992
77. Bekker A, Cooper PR, Frempong-Boadu A, Babu R, Errico T, Lebovits A: Evaluation of preoperative administration of the cyclooxygenase-2 inhibitor rofecoxib for the treatment of postoperative pain after lumbar disc surgery. Neurosurgery 2002; 50:1053-7
78. Chang DJ, Fricke JR, Bird SR, Bohidar NR, Dobbins TW, Geba GP: Rofecoxib versus codeine/acetaminophen in postoperative dental pain: a double-blind, randomized, placebo- and active comparator-controlled clinical trial. Clin Ther 2001; 23:1446-55
79. Chang DJ, Desjardins PJ, Chen E, Polis AB, McAvoy, M, Mockoviak SH, Geba GP: Comparison of the analgesic efficacy of rofecoxib and enteric-coated diclofenac sodium in the treatment of postoperative dental pain: A randomized, placebo-controlled clinical trial. Clin Ther 2002: 24:490-503
80. Fricke J, Varkalis J, Zwillich S, Adler R, Forester E, Recker DP, Verburg KM: Valdecoxib is more efficacious than rofecoxib in relieving pain associated with oral surgery. Am J Ther 2002; 9:89-97
81. Malmstrom K, Daniels S, Kotey P, Seidenberg BC, Desjardins PJ: Comparison of rofecoxib and celecoxib, two cyclooxygenase-2 inhibitors, in postoperative dental pain: A randomized, placebo- and active-comparator-controlled clinical trial. Clin Ther 1999; 21:1653-63
82. Morrison BW, Christensen S, Yuan W, Brown J, Amlani S, Seidenberg B: Analgesic efficacy of the cyclooxygenase-2-specific inhibitor rofecoxib in post-dental surgery pain: A randomized, controlled trial. Clin Ther 1999; 21:943-53
83. Morrison BW, Fricke J, Brown J, Yuan W, Kotey P, Mehlisch D: The optimal analgesic dose of rofecoxib: Overview of six randomized controlled trials. J Am Dent Assoc 2000; 131:1729-37
84. Reicin A, Brown J, Jove M, deAndrade JR, Bourne M, Krupa D, Walters D, Seidenberg B: Efficacy of single-dose and multidose rofecoxib in the treatment of post-orthopedic surgery pain. Am J Orthop 2001; 30:40-8
85. Reuben SS, Connelly NR: Postoperative analgesic effects of celecoxib or rofecoxib after spinal fusion surgery. Anesth Analg 2000; 91:1221-5
86. Reuben SS, Bhopatkar S, Maciolek H, Joshi W, Sklar J: The preemptive analgesic effect of rofecoxib after ambulatory arthroscopic knee surgery. Anesth Analg 2002; 94:55-9
87. Reuben SS, Fingeroth R, Krushell R, Maciolek H: Evaluation of the safety and efficacy of the perioperative administration of rofecoxib for total knee arthroplasty. J Arthroplasty 2002; 17:26-31
88. Turan A, Emet S, Karamanlioglu B, Memis D, Turan N, Pamukcu Z: Analgesic effects of rofecoxib in ear-nose-throat surgery. Anesth Analg 2002; 95:1308-11
89. Huang JJ, Taguchi A, Hsu H, Andriole GL Jr, Kurz A: Preoperative oral rofecoxib does not decrease postoperative pain or morphine consumption in patients after radical prostatectomy: A prospective, randomized, double-blinded, placebo-controlled trial. J Clin Anesth 2001; 13:94-7
90. Pickering AE, Bridge HS, Nolan J, Stoddart PA: Double-blind, placebo-controlled analgesic study of ibuprofen or rofecoxib in combination with paracetamol for tonsillectomy in children. Br J Anaesth 2002; 88:72-7
91. Gimbel JS, Brugger A, Zhao W, Verburg KM, Geis GS: Efficacy and tolerability of celecoxib versus hydrocodone/acetaminophen in the treatment of pain after ambulatory orthopedic surgery in adults. Clin Ther 2001; 23:228-41
92. Khan AA, Brahim JS, Rowan JS, Dionne RA: In vivo selectivity of a selective cyclooxygenase 2 inhibitor in the oral surgery model. Clin Pharm Ther 2002; 72:44-9
93. Doyle G, Jayawardena S, Ashraf E, Cooper SA: Efficacy and tolerability of nonprescription ibuprofen versus celecoxib for dental pain. J Clin Pharmacol 2002; 42:912-9
94. Issioui T, Klein KW, White PF, Watcha MF, Coloma M, Skrivanek GD, Jones SB, Thornton KC, Marple BF: The efficacy of premedication with celecoxib and acetaminophen in preventing pain after otolaryngologic surgery. Anesth Analg 2002; 94:1188-93
95. Daniels SE, Grossman EH, Kuss ME, Talwalker S, Hubbard RC: A double-blind, randomized comparison of intramuscularly and intravenously administered parecoxib sodium versus ketorolac and placebo in a post-oral surgery pain model. Clin Ther 2001; 23:1018-31
96. Desjardins PJ, Grossman EH, Kuss ME, Talwalker S, Dhadda S, Baum D, Hubbard RC: The injectable cyclooxygenase-2-specific inhibitor parecoxib sodium has analgesic efficacy when administered preoperatively. Anesth Analg 2001; 93:721-7
97. Rasmussen GL, Steckner K, Hogue C, Torri S, Hubbard RC: Intravenous parecoxib sodium for acute pain after orthopedic knee surgery. Am J Orthop 2002; 31:336-43
98. Tang J, Li S, White PF, Chen X, Wender RH, Quon R, Sloninsky A, Naruse R, Kariger R, Webb T, Norel E: Effect of parecoxib, a novel intravenous cyclooxygenase type-2 inhibitor, on the postoperative opioid requirement and quality of pain control. ANESTHESIOLOGY 2002; 96:1305-9
99. Barton SF, Langeland FF, Snabes MC, LeComte D, Kuss ME, Dhadda SS, Hubbard RC: Efficacy and safety of intravenous parecoxib sodium in relieving acute postoperative pain following gynecologic laparotomy surgery. ANESTHESIOLOGY 2002; 97:306-14
100. Camu F, Beecher T, Recker DP, Verburg KM: Valdecoxib, a COX-2-specific inhibitor, is an efficacious, opioid-sparing analgesic in patients undergoing hip arthroplasty. Am J Ther 2002; 9:43-51
101. Desjardins PJ, Shu VS, Recker DP, Verburg KM, Wooff CJ: A single preopcrative oral dose of valdecoxib, a new cyclooxygenase-2 specific inhibitor, relieves post-oral surgery or bunionectomy pain. ANESTHESIOLOGY 2002; 97:565-73
102. Ragot JP, Monti T, Macciocchi A: Controlled clinical investigation of acute analgesic activity of nimesulide in pain after oral surgery. Drugs 1993; 46(suppl 1):162-7
103. Thompson JP, Sharpe P, Kiani S, Owen-Smith O: Effect of meloxicam on postoperative pain after abdominal hysterectomy. Br J Anaesth 2000; 84:151-4
104. Barden J, Edwards JE, McQuay HJ, Moore R: Single-dose rofecoxib for acute postoperative pain in adults: A quantitative systematic review. BMC Anesthesiol 2002; 2:4
105. Smiles J, Walker R: Selective cyclo-oxygenase-2 inhibitor-induced oliguria: A postoperative complication. Intern Med J 2001; 31:497-8
106. Bonnel RA, Villalba ML, Karwoski CB, Beitz J: Aseptic meningitis associated with rofecoxib. Arch Intern Med 2002; 162:713-5
107. Cousins M, Power I: Acute and postoperative pain, Textbook of Pain, 4th edition. Edited by Wall PD, Melzack R. Edinburgh, Churchill Livingstone, 1999
108. Mather LE, Cousins MJ: The pharmacological relief of pain: Contemporary issues. Med J Aust 1992; 156:796-802
109. Hill CS Jr: When will adequate pain treatment be the norm? JAMA 1995; 274:1881-2
110. Woodhouse A, Mather LE: Nausea and vomiting in the postoperative patient-controlled analgesia environment. Anaesthesia 1997; 52:770-5
111. Kehlet H: Multimodal approach to control postoperative pathophysiology and rehabilitation. Br J Anaesth 1997; 78:606-17
112. Ballantyne JC, Carr DB, deFerranti S, Suarez T, Lau J, Chalmers TC, Angelillo IF, Mosteller F: The comparative effects of postoperative analgesic therapies on pulmonary outcome: Cumulative meta-analyses of randomized, controlled trials. Anesth Analg 1998; 86:598-612
113. Dimar JR II, Ante WA, Zhang YP, Glassman SD: The effects of nonsteroidal anti-inflammatory drugs on posterior spinal fusions in the rat. Spine 1996; 21:1870-6
114. Deguchi M, Rapoff AJ, Zdeblick TA: Posterolateral fusion for isthmic spondylolisthesis in adults: Analysis of fusion rate and clinical results. J Spinal Disord 1998; 11:459-64
115. Long J, Lewis S, Kuklo T, Zhu Y, Riew KD: The effect of cyclooxygenase-2 inhibitors on spinal fusion. J Bone Joint Surg Am 2002; 84:1763-8
116. Reuben SS: A new class of COX-2 inhibitors offer an alternative to NSAIDs in pain management after spinal surgery. Spine 2001; 26:1505-6
117. Zhang X, Schwarz EM, Young DA, Puzas JE, Rosier RN, O'Keefe RJ: Cyclooxygenase-2 regulates mesenchymal cell differentiation into the osteoblast lineage and is critically involved in bone repair. J Clin Invest 2002; 109:1405-15
118. Matsumura J: Considerations in the use of COX-2 inhibitors in spinal fusion surgery. Anesth Analg 2001; 93:803-4
119. Moiniche S, Hjortso NC, Hansen BL, Dahl JB, Rosenberg J, Gebuhr P, Kehlet H: The effect of balanced analgesia on early convalescence after major orthopaedic surgery. Acta Anaesthesiol Scand 1994; 38:328-35
120. Chenevard R, Hurlimann D, Bechir M, Enseleit F, Spieker L, Hermann M, Riesen W, Gay S, Gay RE, Neidhart M, Michel B, Luscher TF, Noll G, Ruschitzka F: Selective COX-2 inhibition improves endothelial function in coronary artery disease. Circulation 2003; 107:405-9
121. White WB, Faich G, Whelton A, Maurath C, Ridge NJ, Verburg KM, Geis GS, Lefkowith JB: Comparison of thromboembolic events in patients treated with celecoxib, a cyclooxygenase-2 specific inhibitor, versus ibuprofen or diclofenac. Am J Cardiol 2002; 89:425-30
122. Ray WA, Stein CM, Hall K, Daugherty JR, Griffin MR: Non-steroidal anti-inflammatory drugs and risk of serious coronary heart disease: An observational cohort study. Lancet 2002; 359:118-23
123. Issioui T, Klein KW, White PF, Watcha MF, Skrivanek GD, Jones SB, Hu J, Marple BF, Ing C: Cost-efficacy of rofecoxib versus acetaminophen for preventing pain after ambulatory surgery. ANESTHESIOLOGY 2002; 97:931-7
124. Pallapies D, Salinger A, Meyer zum Gottesberge A, Atkins DJ, Rohleder G, Nagyivanyi P, Peskar BA: Effects of lysine clonixinate and ketorolac tromethamine on prostanoid release from various rat organs incubated ex vivo. Life Sci 1995; 57:83-9
125. Kato M, Nishida S, Kitasato H, Sakata N, Kawai S: Cyclooxygenase-1 and cyclooxygenase-2 selectivity of non-steroidal anti-inflammatory drugs: Investigation using human peripheral monocytes. J Pharm Pharmacol 2001; 53:1679-85